Magnesium infusion for vasospasm prophylaxis after subarachnoid hemorrhage

Journal of Neurosurgery

Volumn 105, Issue 5, 2006, Pages 723-729

  Stippler, Martina ^a   Crago, Elizabeth ^b   Levy, Elad I ^b   Kerr, Mary E ^b   Yonas, Howard ^b   Horowitz, Michael B ^b   Kassam, Amin ^b  

^a PRESBYTERIAN UNIVERSITY HOSPITAL   (United States)

^b NONE

Author keywords

Aneurysm; Prophylaxis; Subarachnoid hemorrhage; Vasospasm

Indexed keywords

MAGNESIUM SULFATE;

ADULT; AGED; ANEURYSM RUPTURE; ARTICLE; BRAIN VASOSPASM; CLINICAL TRIAL; COMPUTED TOMOGRAPHIC ANGIOGRAPHY; COMPUTER ASSISTED TOMOGRAPHY; CONTINUOUS INFUSION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEMOGRAPHY; DIGITAL SUBTRACTION ANGIOGRAPHY; DOPPLER ECHOGRAPHY; DRUG EFFICACY; FEMALE; GLASGOW OUTCOME SCALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; PRIORITY JOURNAL; PROGNOSIS; PROPHYLAXIS; RANKIN SCALE; SUBARACHNOID HEMORRHAGE; TREATMENT OUTCOME;

EID: 33750686615     PISSN: 00223085     EISSN: 00223085     Source Type: Journal    
DOI: 10.3171/jns.2006.105.5.723     Document Type: Article

References (50)

1. Afanas'ev IB, Suslova TB, Cheremisina ZP, Abramova NE, Korkina LG: Study of antioxidant properties of metal aspartates. Analyst 120:859-862, 1995
2. Aisenbrey GA, Corwin E, Catanzarite V: Effect of magnesium sulfate on the vascular actions of norepinephrine and angiotensin II. Am J Perinatol 9:477-480, 1992
3. Anonymous: ISIS-4: a randomised factorial trial assessing early oral captopril, oral mononitrate, and intravenous magnesium sulphate in 58, 050 patients with suspected acute myocardial infarction. ISIS-4 (Fourth International Study of Infarct Survival) Collaborative Group. Lancet 345:669-685, 1995
4. Bartrup JT, Stone TW: Presynaptic actions of adenosine are magnesium-dependent. Neuropharmacology 27:761-763, 1988
5. Belfort MA, Anthony J, Saade GR, Allen JC Jr: A comparison of magnesium sulfate and nimodipine for the prevention of eclampsia. N Engl J Med 348:304-311, 2003
6. Boet R, Mee E: Magnesium sulfate in the management of patients with Fisher Grade 3 subarachnoid hemorrhage: a pilot study. Neurosurgery 47:602-607, 2000
7. Brewer RP, Parra A, Lynch J, Chilukuri V, Borel CO: Cerebral blood flow velocity response to magnesium sulfate in patients after subarachnoid hemorrhage. J Neurosurg Anesthesiol 13:202-206, 2001
8. Brocard JB, Rajdev S, Reynolds IJ: Glutamate-induced increases in intracellular free Mg2+ in cultured cortical neurons. Neuron 11:751-757, 1993
9. Chi OZ, Pollak P, Weiss HR: Effects of magnesium sulfate and nifedipine on regional cerebral blood flow during middle cerebral artery ligation in the rat. Arch Int Pharmacodyn Ther 304:196-205, 1990
10. Chia RY, Hughes RS, Morgan MK: Magnesium: a useful adjunct in the prevention of cerebral vasospasm following aneurysmal subarachnoid haemorrhage. J Clin Neurosci 9:279-281, 2002
11. Clozel M, Watanabe H: BQ-123, a peptidic endothelin ETA receptor antagonist, prevents the early cerebral vasospasm following subarachnoid hemorrhage after intracisternal but not intravenous injection. Life Sci 52:825-834, 1993
12. Dorsch NW: Therapeutic approaches to vasospasm in subarachnoid hemorrhage. Curr Opin Crit Care 8:128-133, 2002
13. Feigin VL, Rinkel GJ, Algra A, Vermeulen M, van Gijn J: Calcium antagonists in patients with aneurysmal subarachnoid hemorrhage: a systematic review. Neurology 50:876-883, 1998
14. Frandsen A, Schousboe A: Effect of magnesium on NMDA mediated toxicity and increases in [Ca2+]i and cGMP in cultured neocortical neurons: evidence for distinct regulation of different responses. Neurochem Int 25:301-308, 1994
15. Fuchs-Buder T, Tramer MR, Tassonyi E: Cerebrospinal fluid passage of intravenous magnesium sulfate in neurosurgical patients. J Neurosurg Anesthesiol 9:324-328, 1997
16. Garcia LA, Dejong SC, Martin SM, Smith RS, Buettner GR, Kerber RE: Magnesium reduces free radicals in an in vivo coronary occlusion-reperfusion model. J Am Coll Cardiol 32:536-539, 1998
17. Haley EC Jr, Kassell NF, Torner JC, Truskowski LL, Germanson TP: A randomized trial of two doses of nicardipine in aneurysmal subarachnoid hemorrhage. A report of the Cooperative Aneurysm Study. J Neurosurg 80:788-796, 1994
18. Hamada J, Mizuno T, Kai Y, Morioka M, Ushio Y: Microcatheter intrathecal urokinase infusion into cisterna magna for prevention of cerebral vasospasm: preliminary report. Stroke 31:2141-2148, 2000
19. Hongo K, Kassell NF, Nakagomi T, Sasaki T, Tsukahara T, Ogawa H, et al: Subarachnoid hemorrhage inhibition of endothelium-derived relaxing factor in rabbit basilar artery. J Neurosurg 69:247-253, 1988
20. Janjua N, Mayer SA: Cerebral vasospasm after subarachnoid hemorrhage. Curr Opin Crit Care 9:113-119, 2003
21. Johnson JW, Ascher P: Voltage-dependent block by intracellular Mg2+ of N-methyl-D-aspartate-activated channels. Biophys J 57:1085-1090, 1990
22. Kassell NF, Helm G, Simmons N, Phillips CD, Cail WS: Treatment of cerebral vasospasm with intra-arterial papaverine. J Neurosurg 77:848-852, 1992
23. Kemp PA, Gardiner SM, March JE, Rubin PC, Bennett T: Assessment of the effects of endothelin-1 and magnesium sulphate on regional blood flows in conscious rats, by the colored microsphere reference technique. Br J Pharmacol 126:621-626, 1999
24. Kodama N, Sasaki T, Kawakami M, Sato M, Asari J: Cisternal irrigation therapy with urokinase and ascorbic acid for prevention of vasospasm after aneurysmal subarachnoid hemorrhage. Outcome in 217 patients. Surg Neurol 53:110-118, 2000
25. Kramer JH, Misik V, Weglicki WB: Magnesium-deficiency potentiates free radical production associated with postischemic injury to rat hearts: vitamin E affords protection. Free Radic Biol Med 16:713-723, 1994
26. Kurgan A, Gertz SD, Wajnberg RS, Eldor A, Jersky J, Nelson E: Effect of magnesium sulfate on platelet deposition in rabbits following temporary arterial occlusion with surgical clips. Surgery 87:390-396, 1980
27. Kwan AL, Lin CL, Yanamoto H, Howng SL, Kassell NF, Lee KS: Systemic administration of the potassium channel activator cromakalim attenuates cerebral vasospasm after experimental subarachnoid hemorrhage. Neurosurgery 42:347-351, 1998
28. Kynczl-Leisure M, Cibils LA: Increased bleeding time after magnesium sulfate infusion. Am J Obstet Gynecol 175:1293-1294, 1996
29. Lindegaard KF, Nornes H, Bakke SJ, Sorteberg W, Nakstad P: Cerebral vasospasm after subarachnoid haemorrhage investigated by means of transcranial Doppler ultrasound. Acta Neurochir Suppl 42:81-84, 1988
30. Macdonald RL, Curry DJ, Aihara Y, Zhang ZD, Jahromi BS, Yassari R: Magnesium and experimental vasospasm. J Neurosurg 100:106-110, 2004
31. Mass H, Santoni F, Pirazzi B: On the use of parenteral magnesium salts in the treatment of acute ischaemic heart disease: a brief review. Magnes Res 6:275-289, 1993
32. Maulik D, Zanelli S, Numagami Y, Ohnishi ST, Mishra OP, Delivoria-Papadopoulos M: Oxygen free radical generation during in-utero hypoxia in the fetal guinea pig brain: the effects of maturity and of magnesium sulfate administration. Brain Res 817:117-122, 1999
33. McIntosh TK, Vink R, Yamakami I, Faden AI: Magnesium protects against neurological deficit after brain injury. Brain Res 482:252-260, 1989
34. Muir KW: Magnesium for neuroprotection in ischaemic stroke: rationale for use and evidence of effectiveness. CNS Drugs 15:921-930, 2001
35. Muir KW, Lees KR: Dose optimization of intravenous magnesium sulfate after acute stroke. Stroke 29:918-923, 1998
36. Muir KW, Lees KR, Ford I, Davis S: Magnesium for acute stroke (Intravenous Magnesium Efficacy in Stroke trial): randomised controlled trial. Lancet 363:439-445, 2004
37. Otawara Y, Ogasawara K, Ogawa A, Sasaki M, Takahashi K: Evaluation of vasospasm after subarachnoid hemorrhage by use of multislice computed tomographic angiography. Neurosurgery 51:939-943, 2002
38. Pasqualin A: Epidemiology and pathophysiology of cerebral vasospasm following subarachnoid hemorrhage. J Neurosurg Sci 42 (Suppl 1):15-21, 1998
39. Pyne GJ, Cadoux-Hudson TA, Clark JF: Platelets play an essential role in the aetiology of cerebral vasospasm after subarachnoid haemorrhage. Med Hypotheses 60:525-530, 2003
40. Ram Z, Sadeh M, Shacked I, Sahar A, Hadani M: Magnesium sulfate reverses experimental delayed cerebral vasospasm after subarachnoid hemorrhage in rats. Stroke 22:922-927, 1991
41. Ravn HB, Kristensen SD, Vissinger H, Husted SE: Magnesium inhibits human platelets. Blood Coagul Fibrinolysis 7:241-244, 1996
42. Ravn HB, Vissinger H, Kristensen SD, Wennmalm A, Thygesen K, Husted SE: Magnesium inhibits platelet activity - an infusion study in healthy volunteers. Thromb Haemost 75:939-944, 1996
43. Sloan MA, Alexandrov AV, Tegeler CH, Spencer MP, Caplan LR, Feldmann E, et al: Assessment: transcranial Doppler ultrasonography: report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology. Neurology 62:1468-1481, 2004
44. Sze KH, Sim TC, Wong E, Cheng S, Woo J: Effect of nimodipine on memory after cerebral infarction. Acta Neurol Scand 97:386-392, 1998
45. Torregrosa G, Perales AJ, Salom JB, Miranda FJ, Barbera MD, Alborch E: Different effects of Mg2+ on endothelin-1- and 5-hydroxytryptamine-elicited responses in goat cerebrovascular bed. J Cardiovasc Pharmacol 23:1004-1010, 1994
46. van den Bergh WM, Zuur JK, Kamerling NA, van Asseldonk JT, Rinkel GJ, Tulleken CA, et al: Role of magnesium in the reduction of ischemic depolarization and lesion volume after experimental subarachnoid hemorrhage. J Neurosurg 97:416-422, 2002
47. Veyna RS, Seyfried D, Burke DG, Zimmerman C, Mlynarek M, Nichols V, et al: Magnesium sulfate therapy after aneurysmal subarachnoid hemorrhage. J Neurosurg 96:510-514, 2002
48. Vink R, Cernak I: Regulation of intracellular free magnesium in central nervous system injury. Front Biosci 5:D656-D665, 2000
49. Widner B, Werner ER, Schennach H, Wachter H, Fuchs D: Simultaneous measurement of serum tryptophan and kynurenine by HPLC. Clin Chem 43:2424-2426, 1997
50. Zuccarello M, Bonasso CL, Lewis AI, Sperelakis N, Rapoport RM: Relaxation of subarachnoid hemorrhage-induced spasm of rabbit basilar artery by the K+ channel activator cromakalim. Stroke 27:311-316, 1996